Evidence map›Paper›PMID 30183489›Full record

ReviewOrganogenesis2018

Utility of extracellular matrix powders in tissue engineering.

Lauren Edgar, Afnan Altamimi, Marta García Sánchez, Riccardo Tamburrinia, Amish Asthana, Carlo Gazia, Giuseppe Orlando

Abstract readReview
In one paragraph

Review in Organogenesis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. World journal of gastroenterology · 2019
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Application of decellularized tissue for soft-hard interregional regeneration.Frontiers in bioengineering and biotechnology · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lauren Edgara Wake Forest School of Medicine, Department of Surgery , Winston-Salem , NC , USA.ORCID 0000-0003-2923-7952
Afnan Altamimib Wake Forest Institute for Regenerative Medicine, Department of Surgery , Winston-Salem , NC , USA.
Marta García Sánchezd Universidad San Pablo CEU, Escuela de Medicina , Madrid , Spain.
Riccardo Tamburriniaa Wake Forest School of Medicine, Department of Surgery , Winston-Salem , NC , USA.ORCID 0000-0002-2916-2666
Amish Asthanab Wake Forest Institute for Regenerative Medicine, Department of Surgery , Winston-Salem , NC , USA.
Carlo Gaziab Wake Forest Institute for Regenerative Medicine, Department of Surgery , Winston-Salem , NC , USA.
Giuseppe Orlandoa Wake Forest School of Medicine, Department of Surgery , Winston-Salem , NC , USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extracellular matrix (ECM) materials have had remarkable success as scaffolds in tissue engineering (TE) and as therapies for tissue injury whereby the ECM microenvironment promotes constructive remodeling and tissue regeneration. ECM powder and solubilized derivatives thereof have novel applications in TE and RM afforded by the capacity of these constructs to be dynamically modulated. The powder form allows for effective incorporation and penetration of reagents; hence, ECM powder is an efficacious platform for 3D cell culture and vehicle for small molecule delivery. ECM powder offers minimally invasive therapy for tissue injury and successfully treatment for wounds refractory to first-line therapies. Comminution of ECM and fabrication of powder-derived constructs, however, may compromise the biological integrity of the ECM. The current lack of optimized fabrication protocols prevents a more extensive and effective clinical application of ECM powders. Further study on methods of ECM powder fabrication and modification is needed.

Indexed as

AnimalsExtracellular MatrixHumansPowdersPrinting, Three-DimensionalSterilizationTissue EngineeringPowderscomminutionextracellular matrixpowderpulverizationregenerative medicinetissue engineering

Identifiers

PMID30183489
PMCPMC6300104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.